Cargando…

Clinical features and seasonal variations in the prevalence of macrolide‐resistant Mycoplasma pneumoniae

BACKGROUND: Mycoplasma pneumoniae is a common pathogen causing pneumonia; macrolide‐resistant strains are rapidly spreading across Japan. However, the clinical features of macrolide‐resistant M. pneumoniae pneumonia have not been well established. Here, we evaluated the clinical characteristics and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akashi, Yusaku, Hayashi, Daisuke, Suzuki, Hiromichi, Shiigai, Masanari, Kanemoto, Koji, Notake, Shigeyuki, Ishiodori, Takumi, Ishikawa, Hiroichi, Imai, Hironori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238234/ https://www.ncbi.nlm.nih.gov/pubmed/30464865 http://dx.doi.org/10.1002/jgf2.201

Ejemplares similares

The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan
por: Takeuchi, Yuto, et al.
Publicado: (2021)

Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study
por: Takeuchi, Yuto, et al.
Publicado: (2021)

Diagnostic performance of microscopic stool examination in Campylobacter infection performed by different medical specialties
por: Hirose, Yumi, et al.
Publicado: (2022)

A Prospective Evaluation of the Analytical Performance of GENECUBE(®) HQ SARS-CoV-2 and GENECUBE(®) FLU A/B
por: Kiyasu, Yoshihiko, et al.
Publicado: (2021)

A case of severe pneumonia with viremia caused by adenovirus B7 identified by off-label use of a multiplex PCR system
por: Sakakura, Akie, et al.
Publicado: (2020)

Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2
por: Akashi, Yusaku, et al.
Publicado: (2022)

Prospective analytical performance evaluation of the QuickNavi™-COVID19 Ag for asymptomatic individuals()
por: Kiyasu, Yoshihiko, et al.
Publicado: (2021)

The evaluation of the utility of the GENECUBE HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol
por: Naito, Asami, et al.
Publicado: (2021)

Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): A prospective observational study with nasopharyngeal samples
por: Suzuki, Hiromichi, et al.
Publicado: (2022)

The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2
por: Kurihara, Yoko, et al.
Publicado: (2021)

Clinical evaluation of the rapid nucleic acid amplification point-of-care test (Smart Gene SARS-CoV-2) in the analysis of nasopharyngeal and anterior nasal samples()
por: Kiyasu, Yoshihiko, et al.
Publicado: (2022)

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
por: Miyashita, Naoyuki, et al.
Publicado: (2012)

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010
por: Averbuch, Diana, et al.
Publicado: (2011)

Macrolide-Resistant Mycoplasma pneumoniae, United States
por: Zheng, Xiaotian, et al.
Publicado: (2015)

Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan
por: Wu, Han-Meng, et al.
Publicado: (2012)

Prospective study of three saliva qualitative antigen testing kits for the detection of SARS-CoV-2 among mainly symptomatic patients in Japan
por: Terada, Norihiko, et al.
Publicado: (2023)

Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids
por: Han, Hye Young, et al.
Publicado: (2021)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Seo, Young Ho, et al.
Publicado: (2014)

The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
por: Oh, Jae-Won
Publicado: (2014)

Drug Resistance Mechanisms of Mycoplasma pneumoniae to Macrolide Antibiotics
por: Liu, Xijie, et al.
Publicado: (2014)

Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment
por: Pereyre, Sabine, et al.
Publicado: (2016)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia
por: Zhou, Yajuan, et al.
Publicado: (2020)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
por: Chen, Yu-Chin, et al.
Publicado: (2020)

Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients
por: Ishiguro, Nobuhisa, et al.
Publicado: (2017)

Construction of a Nomogram for Identifying Refractory Mycoplasma pneumoniae Pneumonia Among Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Xie, Qiaoyi, et al.
Publicado: (2022)

Macrolide Resistance of Mycoplasma pneumoniae, South Korea, 2000–2011
por: Hong, Ki Bae, et al.
Publicado: (2013)

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015
por: Tanaka, Takaaki, et al.
Publicado: (2017)

Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA
por: Lanata, Mariana M., et al.
Publicado: (2021)

Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae
por: Komatsu, Haruki, et al.
Publicado: (2014)

Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children
por: Ha, Seok Gyun, et al.
Publicado: (2018)

Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Yang, Eun-Ae, et al.
Publicado: (2017)

A Case of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Pregnancy Treated with Garenoxacin
por: Matsuda, Yoko, et al.
Publicado: (2017)

Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong
Publicado: (2019)

Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children
por: Lee, Eun, et al.
Publicado: (2017)

Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children
por: Yang, Hyeon-Jong, et al.
Publicado: (2017)

Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
por: Lee, Hyunju, et al.
Publicado: (2021)

Increased Macrolide Resistance Rate of M3562 Mycoplasma pneumoniae Correlated With Macrolide Usage and Genotype Shifting
por: Wang, Yacui, et al.
Publicado: (2021)

Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae
por: Narita, Mitsuo
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uioh8il6u5l21s9e2ce7mkmaeq